Graybug Vision Operating Expenses 2011-2025 | GRAY

Annual Operating Expenses Graybug Vision

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
38.1 M	14.2 M	35.9 M	29.8 M	37.5 M	28.6 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
38.1 M	14.2 M	30.7 M

Quarterly Operating Expenses Graybug Vision

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
5.62 M	6.62 M	6.5 M	-	5.74 M	6.53 M	5.77 M	-	4.83 M	6.58 M	22.3 M	-	3.29 M	3.59 M	4.21 M	-	8.02 M	7.74 M	11.5 M	-	6.82 M	6.04 M	7.8 M	-	10.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
22.3 M	3.29 M	7.36 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Aclaris Therapeutics ACRS	92.7 M	$ 3.03	-	$ 234 M	USA
Aptevo Therapeutics APVO	-31.8 M	$ 0.61	-	$ 168 K	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.67	-	$ 426 M	Britain
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.12	0.81 %	$ 7.51 B	Australia
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	20.7 M	$ 1.14	-	$ 6.22 M	China
BioVie BIVI	18.1 M	$ 1.21	-	$ 1.79 M	USA
Aeglea BioTherapeutics AGLE	209 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Ascendis Pharma A/S ASND	338 M	$ 208.98	-	$ 5 B	Danmark
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 0.21	-	$ 457 M	Israel
Bellicum Pharmaceuticals BLCM	28.5 M	-	-9.72 %	$ 5.89 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	141 M	-	-15.15 %	$ 60.3 M	Britain
Catalyst Biosciences CBIO	176 M	$ 12.35	-0.16 %	$ 813 M	USA
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Certara CERT	232 M	$ 8.89	-	$ 1.43 B	USA
BioNTech SE BNTX	512 M	$ 94.52	-	$ 27.2 B	Germany
Amphastar Pharmaceuticals AMPH	168 M	$ 27.12	-	$ 1.31 B	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	125 M	-	-10.95 %	$ 876 K	USA
Anika Therapeutics ANIK	51.6 M	$ 9.55	-	$ 140 M	USA
bluebird bio BLUE	854 M	-	-	$ 546 M	USA
Arena Pharmaceuticals ARNA	427 M	-	-6.81 %	$ 3.04 B	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Axon Enterprise AXON	1.18 B	$ 583.84	-	$ 44.2 B	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Corcept Therapeutics Incorporated CORT	189 M	$ 82.65	-	$ 8.53 B	USA
Aytu BioScience AYTU	53.7 M	$ 2.45	-3.16 %	$ 15.4 M	USA
ChromaDex Corporation CDXC	53.9 M	-	-0.88 %	$ 598 M	USA
AstraZeneca PLC AZN	17.6 B	$ 92.9	-	$ 96.9 B	Britain
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
Burford Capital Limited BUR	106 M	$ 9.09	-	$ 1.47 B	Britain
Celldex Therapeutics CLDX	58.1 M	$ 26.4	-	$ 1.7 M	USA